OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Trial protocol
Highlighted
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Project:
Cancer
Categories:
Study Design
198 Publications
found
Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program.
b
JCO precision oncology
February 1, 2023
p
Cancer
c
Clinical outcomes
Economics
Highlighted
Model
Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis.
b
NPJ genomic medicine
January 20, 2023
p
Cancer
c
Change patient management
Clinical outcomes
Observational
A global analysis of the value of precision medicine in oncology – The case of non-small cell lung cancer.
b
Frontiers in medicine
January 1, 2023
p
Cancer
c
Economics
Highlighted
Model
Molecular analysis for refractory rare cancers: Sequencing battle continues – learnings for the MOSCATO-01 study.
b
Critical reviews in oncology/hematology
January 1, 2023
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
b
JCO precision oncology
January 1, 2023
p
Cancer
c
Change patient management
Observational
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system.
b
Neuro-oncology advances
January 1, 2023
p
Cancer
c
Change patient management
Clinical outcomes
Observational
A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data.
b
Future oncology (London, England)
January 1, 2023
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.
b
Neuro-oncology advances
January 1, 2023
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway).
b
Frontiers in oncology
January 1, 2023
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital.
b
Frontiers in oncology
January 1, 2023
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Previous Page
1
2
3
4
5
…
20
Next Page
